Kommentar zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Behandlung der akuten und chronischen Herzinsuffizienz

Springer Science and Business Media LLC - Tập 7 Số 2 - Trang 105-114 - 2013
Gerd Hasenfuß1, Stefan D. Anker2, Johann Bauersachs3, Michael Böhm4, Uta C. Hoppe5, Burkert Pieske6, Wolfgang von Scheidt7, Rolf Wachter8
1Herzzentrum Göttingen, UMG, Georg-August-Universität Göttingen, Robert-Koch-Str. 40, 37099, Göttingen, Deutschland
2Charité - Universitätsmedizin Berlin, Berlin, Deutschland
3Klinik für Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover, Deutschland
4Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, Deutschland
5Universitätsklinik für Innere Medizin II, Paracelsus-Universität Salzburg, Salzburg, Österreich
6Klinische Abteilung für Kardiologie, Medizinische Universität Graz, Graz, Österreich
7I. Medizinische Klinik, Klinikum Augsburg, Herzzentrum Augsburg-Schwaben, Augsburg, Deutschland
8Herzzentrum Göttingen, UMG, Georg-August-Universität Göttingen, Göttingen, Deutschland

Tóm tắt

Từ khóa


Tài liệu tham khảo

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012. Eur Heart J 33:1787–1847

ESC Guidelines for the Diagnose and Treatment of Acute and Chronic Heart Failure 2012. Eur J Heart Fail 14:803–869

Meta-analysis Global Group in Chronic Heart Failure (MAGIC) (2012) The survival of patients with heart failure with preserved and reduced left ventricluar ejection fraction: patient data meta-analysis. Eur Heart J 33:1750–1757

Zannad F, McMurray JJ, Krum H et al (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364:11–21

Swedberg K, Komajda M, Bohm M et al (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized placebo-controlled study. Lancet 376:875–885

Taylor AL, Zische S, Yancy C et al (2004) Combination of iosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351:2049–2057

Tavazzi L, Maggioni AP, Marchioli R et al (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet 372:1223–1230

Kiekshus J, Apetrei E, Barrios V et al (2007) Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357:2248–2261

Tavazzi L, Maggioni AP, Marchioli R et al (2008) Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372:1231–1239

Massie BM, Carson PE, McMurray JJ et al (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359:2456–2467

Moss AJ, Hall WJ, Cannom DS et al (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329–1338

Tang AS, Wells GA, Talajic M et al (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363:2385–2395

Sipahi I, Carrigan TP, Rowsland DY et al (2011) Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Arch Intern Med 171:1354–1462

O’Connor CM, Jiang W, Kuchibhatla M et al (2010) Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 56:692–699

Anker SD, Comin Colet J, Filippatos G et al (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361:2436–2448

Gheorghiade M, Konstam MA, Burnett JC Jr et al (2007) Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 297:1332–1343

Thiele H, Zeymer U, Neumann FJ et al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367:1287–1296

Velazquez EJ, Lee KL, Deja MA et al (2011) Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 364:1607–1616

De Bruyne B, Pijls NH, Kalesan B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991–1001

Slaughter MS, Rogers JG, Milano CA et al (2009) Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361:2241–2251

Feldman T, Kar S, Rinaldi M et al (2009) Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 54:686–694

O’Connor CM, Whellan DJ, Lee KL et al (2009) Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301:1439–1450

Edelmann F, Gelbrich G, Düngen HD et al (2011) Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol 58:1780–1791

Inglis SC, Clark RA, McAlister FA et al (2011) Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: abridged cochrane review. Eur J Heart Fail 13:1028–1040